MYSM1 and systemic lupus erythematosus: The higher proportion of Flt3+ B1 cells in systemic lupus erythematosus (SLE) patients suggests a potential role of the MYSM1/miR-150/Flt3 pathway in the pathogenesis of SLE (Figure 3C) [31].